Biomedical Engineering Reference
In-Depth Information
9. Sciadini MF, Dawson JM, Johnson KD. Bovine-derived bone protein as a bone graft substitute in
a canine segmental defect model. J Orthop Trauma 1997; 11:496-508.
10. Sandhu HS, Kanim LE, Toth JM et al. Experimental spinal fusion with recombinant human bone
morphogenetic protein-2 without decortication of osseous elements. Spine 1997; 22:1171-80.
11. Zdeblick TA, Ghanayem AJ, Rapoff AJ et al. Cervical interbody fusion cages. An animal model
with and without bone morphogenetic protein. Spine 1998; 23:758-65.
12. den Boer FC, Bramer JA, Blokhuis TJ et al. Effect of recombinant human osteogenic protein-1 on
the healing of a freshly closed diaphyseal fracture. Bone 2002; 31:158-64.
13. Bruder SP, Fox BS. Tissue engineering of bone. Cell based strategies. Clin Orthop 1999; 367
Suppl:s68-83.
14. Johnson EE, Urist MR, Finerman GA. Bone morphogenetic protein augmentation grafting of re-
sistant femoral nonunions. A preliminary report. Clin Orthop 1988; 230:257-65.
15. Johnson EE, Urist MR, Finerman GA. Distal metaphyseal tibial nonunion. Deformity and bone
loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP).
Clin Orthop 1990; 250:234-40.
16. Johnson EE, Urist MR, Finerman GA. Resistant nonunions and partial or complete segmental
defects of long bones. Treatment with implants of a composite of human bone morphogenetic
protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. Clin Orthop 1992;
277:229-37.
17. Johnson EE, Urist MR. One-stage lengthening of femoral nonunion augmented with human bone
morphogenetic protein. Clin Orthop 1998; 347:105-16.
18. Johnson EE, Urist MR. Human bone morphogenetic protein allografting for reconstruction of
femoral nonunion. Clin Orthop 2000; 371:61-74.
19. Geesink RG, Hoefnagels NH, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic pro-
tein (BMP-7) in a human fibular defect. J Bone Joint Surg 1999; 81-B:710-8.
20. Friedlaender GE, Perry CR, Cole JD et al. Osteogenic protein-1 (bone morphogenetic protein-7)
in the treatment of tibial nonunions. J Bone Joint Surg 2001; 83-A:151-8.
21. Chen X, Kidder LS, Lew WD. Osteogenic protein-1 induced bone formation in an infected seg-
mental defect in the rat femur. J Orthop Research 2002; 20:142-50.
22. Cook SD. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. Or-
thoped 1999; 22:669-71. Review.
23. Giltaij LR, Shimmin A, Friedlaender GE. Osteogenic protein-1 in the repair of bone defects and
fractures of long bones: clinical experience. In: Vukicevic S, Sampath K, eds. Bone Porphogenetic
Proteins. Basel, Switzerland: Birkhäuser Verlag; 2002; 193-205.
24. Cook SD, Barrack RL, Shimmin A et al. The use of osteogenic protein-1 in reconstructive surgery
of the hip. J Arthroplasty 2001; 16:88-94.
25. Riedel GE, Valentin-Opran A. Clinical evaluation of rhBMP-2/ACS in orthopedic trauma: a progress
report. Orthopedi 1999; 22:663-5.
26. Govender S, Csimma C, Genant HK et al. Recombinant human bone morphogenetic protein-2
for treatment of open tibial fractures: a prospective , controlled, randomized study of four hundred
and fifty patients. J Bone Joint Surg 2002; 84-A:2123-34.
27. Cotler JM, Star AM. Complications of spinal fusions. In: Cotler JM, Cotler HB, eds. Spinal fu-
sion: science and technique. New York: Springler-Verlag; 1990.
28. Boden SD, Martin GJ, Horton WC et al. Laparoscopic anterior spinal arthrodesis with rhBMP-2
in a titanium interbody threaded cage. J spinal disorders. 1998; 11:95-101.
29. Burkus JK, Gornet MF, Dickman CA et al. Anterior lumbar interbody fusion using rh-BMP2
with tapered interbody cages. J spinal disorders techniques 2002; 15:337-49.
30. Boden SD, Kang J, Sandhu H et al. Use of recombinant human bone morphogenetic protein-2 to
achieve posterolateral lumbar spine fusion in humans: a prospective randomized clinical pilot trial:
2002 vovlo award in clinical studies. Spine 2002; 27:2662-73.
31. Poynton AR, Lane JM. Safety profile for the clinical use of bone morphogenetic proteins in spine.
Spine 2002; 15:40-8.
32. Ripamonti U, Duneas N. Tissue morphogenesis and regeneration by bone morphogenetic proteins.
Plast Reconstr Surg 1998; 101:227-239.
33. Saito N, Okada T, Horiuchi H et al. A biodegradable polymer as a cytokine delivery system for
inducing bone formation. Nature Biotech 2001; 19:332-5.
34. Cook SD, Rueger DC. Osteogenic protein-1: biology and applications. Clin Orthop 1996;
324:29-38.
35. Valentin-Opran A, Wozney J, Csimma C et al. Clinical evaluation of recombinant human bone
morphogenetic protein-2. Clin Orthop 2002; 395:110-20.
Search WWH ::
Custom Search